Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder

Not Applicable

Active, not recruiting

• Conditions: OCD
• Interventions: Behavioral: Psychotherapy; Other: Pharmacotherapy

• Registration Number: NCT03511534
• Lead Sponsor: Stanford University

Brief Summary

The purpose of this study is to provide participants diagnosed with obsessive compulsive disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with open/aftercare treatment.

Detailed Description

After completing one of the active clinical studies participants have the option to enroll in this protocol that offers open treatment.

The goal is to compare two forms of current standard treatments, psychotherapy vs pharmacotherapy.

Study Timeline

• Study Start: 2017-06-23
• Study First Submitted: 2018-04-18
• Study First Submitted QC: 2018-04-18
• Study First Posted: 2018-04-30
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-22
• Last Update Posted: 2024-05-23
• Primary Completion: 2025-06
• Study Completion: 2026-06

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. Ability to speak and understand English
2. Capacity to consent (e.g. as determined by assessing the patient's understanding of the risks, benefits, and procedures of the study)
3. Completed an active study protocol at the Rodriguez Lab at Stanford University

Read More

Exclusion Criteria

1. Children younger than 18
2. Active suicidality

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Psychotherapy	Psychotherapy	Participants will receive evidenced based psychotherapy by a trained psychologist
Pharmacotherapy	Pharmacotherapy	Participants will receive pharmacotherapy by a psychiatrist

Primary Outcome Measures

Name	Time	Method
Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)	Up to 14 weeks	Improvement in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS.

Trial Locations

Locations (1)

Stanford University; 🇺🇸 Stanford, California, United States